It may be cold out there, but the IPO (initial public offering) The market is not completely frozen. BrightSpring, a company that provides home and community health services, just announced plans to go public. Now investors will likely be watching the development of this offering for clues about further equity offerings this year. The company appears on the list Nasdaq as BTSG stock and is expected to begin trading on January 26th.
According to BrightSpring's press release, 53.33 million shares of BTSG will be issued at a price between $15 and $18 per share. The final prices will be announced before the company's official listing.
Let's dive deeper into what investors can expect from this upcoming IPO.
What to know about BrightSpring's upcoming IPO and BTSG stock
BrightSpring's IPO is expected to raise up to $960 million in capital, excluding the concurrent offering of Tangible Equity units (which could raise around $400 million). The company plans to use these funds to pay down debt, essentially buying out the company's lender. KKR (NYSE:KKR). Meanwhile, the remaining funds will be used for general corporate purposes.
In total, this deal could raise BrightSpring up to $1.36 billion if the IPO is priced at the high end of the range and all options are exercised. As mentioned, investors will likely be paying close attention to how well the underwriting of this deal is – and how investor demand is manifesting itself. A $3 billion valuation is significant and given the health nature of the deal, investors will likely take cues from the deal about the prospects for this sector.
BrightSpring's business model may also be of interest to many investors. The company's focus on home health services for patients with chronic and complex illnesses could certainly lead to stable and consistent growth given changing demographic trends. Personally, this will be an IPO I'll be paying attention to. I plan to provide more updates in the future.
At the time of publication, Chris MacDonald did not hold, directly or indirectly, any positions in the securities mentioned in this article. The opinions expressed in this article are those of the author and are subject to InvestorPlace.com's publication policies.
Chris MacDonald's love of investing led him to pursue an MBA in finance and to take on a number of leadership roles in corporate finance and venture capital over the past 15 years. His past experience as a financial analyst, coupled with his eagerness to find undervalued growth opportunities, contribute to his conservative, long-term investment perspective.
Comments are closed.